Skip to content

Septerna

US · SEPN #2886 by market cap Listed 2024
38.61 -0.59 -1.51%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

✦ Quant Ownership Signal how this is computed

Distributing
  • The number of reporting institutions increased by 6 in the most recent period (2026/Q3).
  • Total institutional ownership fell 4.6 percentage points.

Ownership vs. money flow

Aligned

Institutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Institutional ownership

Held by institutions
100.41% -4.60pp
Institutions
202 +6
As of
2026/Q3 vs. prior period

Holder types

VC/PE Fund46.19%
Mutual Fund40.46%
Hedge Fund8.75%
Public Company4.41%
Individual/Insider2.81%
Private Company0.25%
Government Pension Fund0.21%

Top holders as of 2026-08-12

Third Rock Ventures, LLC 21.62% · 10.28M sh
RA Capital Management, L.P. 11.57% · 5.50M sh
Driehaus Capital Management LLC 9.32% · 4.43M sh
Samsara BioCapital LLC 6.62% · 3.15M sh
BlackRock 4.36% · 2.07M sh
The Goldman Sachs Group, Inc. 3.61% · 1.72M sh
Artal Group S.A. 3.58% · 1.70M sh
Vanguard Capital Management, LLC 2.85% · 1.35M sh
Goldman Sachs Asset Management, L.P. 2.83% · 1.34M sh
Avoro Capital Advisors LLC 2.81% · 1.34M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 29 buys · 21 sells

NameRoleStake
Third Rock Ventures, LLC -- 21.62%
RA Capital Management, L.P. -- 11.57%
Jeffrey Finer Chief Executive Officer 1.63%
Elizabeth Bhatt President 0.37%
Uwe Klein Senior Vice President of Biological Sciences 0.27%
R. Alan Ezekowitz Director 0.25%
Daniel Long Senior Vice President of Drug Discovery 0.20%
Gilbert Labrucherie Chief Financial Officer 0.09%
Samira Shaikhly Chief Human Resources Officer 0.00%
Shalini Sharp Independent Director --

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-11-11 Jeffrey Finer Chief Executive Officer Intent to Sell (Form 144) -66,000 $48.56
2026-11-10 R. Alan Ezekowitz Director Automatic Disposition -81,820 $46.01–51.90
2026-10-14 Elizabeth Bhatt President Derivative Exercise and Sale -4,000 $6.81–37.61
2026-09-30 Daniel Long Senior Vice President of Drug Discovery Intent to Sell (Form 144) -10,001 $39.13
2026-09-30 Samira Shaikhly Chief Human Resources Officer Intent to Sell (Form 144) -12,592 $39.13
2026-09-07 Rajiv Patni Chief Medical Officer Other Derivative Acquisition +275,000 $37.37
2026-08-31 Daniel Long Senior Vice President of Drug Discovery Derivative Exercise and Sale -3,333 $2.76–37.83
2026-08-11 RA Capital Management, L.P. -- Private Disposition -1,493,000 $42.50
2026-08-11 Third Rock Ventures, LLC -- Automatic Disposition -147,200 $50.27–51.08
2026-08-10 Elizabeth Bhatt President Derivative Exercise and Sale -25,000 $2.76–44.00
2026-08-02 Daniel Long Senior Vice President of Drug Discovery Derivative Exercise and Sale -3,334 $2.76–34.68
2026-07-14 Elizabeth Bhatt President Derivative Exercise and Sale -4,000 $6.81–33.99
2026-06-30 Daniel Long Senior Vice President of Drug Discovery Derivative Exercise and Sale -3,333 $2.76–34.81
2026-06-28 Samira Shaikhly Chief Human Resources Officer Derivative Exercise and Sale -2,178 $6.81–35.18
2026-06-25 R. Alan Ezekowitz Director Other Derivative Acquisition +15,000 $37.34
2026-06-25 RA Capital Management, L.P. -- Other Derivative Acquisition +15,000 $37.34
2026-06-25 Shalini Sharp Independent Director Other Derivative Acquisition +15,000 $37.34
2026-06-25 Jeffrey Tong Chairperson Other Derivative Acquisition +15,000 $37.34
2026-06-25 Bernard Coulie Independent Director Other Derivative Acquisition +15,000 $37.34
2026-06-25 Keith Gottesdiener Independent Director Other Derivative Acquisition +11,260 $37.34

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Septerna discussion 0 comments

Add a comment